The capacity of blood platelets to attach themselves aspecifically to antigen-antibody complexes in the presence of complement can be utilized for the demonstration of antibodies formed against homologous tissues.
less than 85 % of the standard are regarded as positive.
Sera collected from patients with 'protracted' acute or chronic hepatitis and cirrhosis were found to be positive with the new method in 68-0 % of the cases; the corresponding figures were 26-3 % for 'non-protracted' acute hepatitis and 18-1 % for diseases of the bile duct. No positive reaction occurred in other internal diseases studied or in healthy persons, but 40 % of subjects with diverse infections gave positive results possibly because of autoantibody formation against tissues damaged by the infections. Comparative examinations suggest that the thrombocyte consumption test is more specific than the antihuman globulin consumption method.
In the presence of all components of complement (Siqueira and Nelson, 1961) blood platelets are aspecifically attached to the complex formed by corpuscular (Lamanna, 1957; Nelson and Nelson, 1959) and soluble antigens (Miescher and Cooper, 1960; Osler, Hawrisiak, Ovary, Siqueira, and Bier, 1957; Siqueira and Nelson, 1961) with their antibodies. This might explain why in states of allergy (Stavitsky, Stavitsky, and Ecker, 1949; Rocha e Silva, 1950; Storck, 1951; Storck, Hoigne, and Koller, 1951; Nilzen, 1953; Rice, 1955; Storck, and Hoigne, 1956; Korossy and Gozony, 1959; Bier and Siqueira, 1959 ) the thrombocyte count diminishes significantly after the administration of homologous antigen. Although it is only in recent years that investigators have gained some insight into these processes, Rieckenberg employed thrombocytes as a specific indicator system for the examination of Leptospira and Trypanosoma antibodies as far back as the year 1917. Hoigne and Storck elaborated in 1953 a thrombocyte-agglutination procedure for the diagnosis of drug sensitivity.
The present investigations were instituted to decide 'Present address: Postgraduate Medical School, Budapest, XIII. if the decrease in the thrombocyte count after antigen-antibody reactions could be used to detect autoantibodies against homologous tissues and organs. The sera of patients suffering from various hepatic disorders were tested, and homogenized human liver was employed as antigen. We compared the results of examinations with the antihuman globulin consumption test carried out simultaneously.
MATERIALS AND METHODS
ANTIGEN The livers of young persons who had died accidentally were washed a few hours after death with 20 1. of ice-cold physiological saline through a cannula inserted into the portal vein, and then homogenized in a Waring blender. The liver brei was washed with ice-cold physiological saline until the last washing fluid gave a negative reaction for protein with a 20% solution of sulphosalicylic acid. The washed liver suspension was then distributed in 1 ml. ampoules and stored at -20°C. The content of each ampoule was suspended in 24 ml. of sterile veronal buffer2 at pH 60-6-2 before use. The antigen suspension contained 5 to 10 mg./ml. of dry matter.
CLINICAL MATERIAL The patients were grouped clinically as follows: 44 cases of acute infective hepatitis, chronic hepatitis, or cirrhosis; 11 of cholecystitis; 15 of other internal diseases, comprising hyperthyroidism, generalized arteriosclerosis, heart injuries, hypertension; 15 of various infectious diseases comprising pneumococcal pneumonia, acute pharingitis, influenza, acute tonsillitis, Bact. coli sepsis, and infectious mononucleosis. Fourteen healthy individuals were included in the trial. Blood was taken from the patients two to five times at weekly intervals; the 14 healthy individuals had only one bleeding. Two hundred and fifty samples were thus collected. The sera of patients were preserved sterile at -20'C. without the addition of any preservative.
STANDARD SERA Sera from five healthy persons were used as standards. The arithmetical mean of the thrombocyte count of these sera was used as the reference serum for values obtained from the test sera. It is advisable to retain large amounts of standard sera for continual reference throughout the tests.
THROMBOCYTE SUSPENSION Human blood platelets were used. Blood, drawn separately for each test from the cubital vein of healthy donors, was collected in a paraffin-or silicone-coated graduated centrifuge tube containing enough 3.8 % sodium citrate to form a 1:5 mixture with the added blood. After centrifuging this mixture for eight minutes at 500 r.p.m., the thrombocyte count in the supernatant fluid was determined. A suspension containing 200,000 to 240,000 thrombocytes/c.mm. was used; if the value turned out to be higher, centrifugation was continued until the desired density was reached when the plasma was transferred to a paraffin-coated test tube, gently stirred, and used without delay. All superfluous mechanical operations which might damage the platelets, e.g., pouring or shaking, must be avoided. The whole procedure should be quick: no more than half an hour must elapse between the withdrawal of blood from the donor and its application. REACTION Carefully cleaned test tubes (70 x 8 mm.), pretreated with sulphuric acid, were employed for the test. The ingredients were pipetted from accurately calibrated pipettes in the following order: 0-5 ml. of the serum to be tested (or 0 5 ml. of the standard sera), 0-1 ml. of the thrombocyte suspension (in the plasma containing fresh Diagnosis thrombocytes complement is introduced to the system), and 0 4 ml. of antigen suspension. (Steffen, 1954; Steffen and Schindler, 1955) with the antigen referred to above. The reaction was considered positive provided that the Coombs serum showed a twofold or even bigger decrease in titre.
RESULTS
The number of thrombocytes in the test sera, expressed as the percentage of the arithmetical mean of the thrombocyte values in the standards, is shown in Table I shows that there is a correlation between the clinical picture and the decrease in the thrombocyte count. The boundary between positively and negatively reacting test sera was found to be at 85% of the standard, and at this level the best correlation with the clinical state as well as with the results of the antihuman globulin consumption test carried out at the same time (Table II) was found. Test sera with a thrombocyte count below this value will be termed 'positive' and those above it will be called 'negative'. 'Negative' only applies to those patients whose sera had never given a positive reaction. Seventeen patients of the first group in Table 11 were 'positive' so serum from these patients was collected on 60 occasions, and positive reactions in 33 and negative in 27 instances were obtained. The reaction turned most frequently negative when the patient had received corticosteroids (Table III) , a finding in accordance with the results of Vorlander (1954) , Rissel, Steffen, and Wewalka (1957) , Osztovics, Marcsek, and Szisz (1962) . One or two days after starting administration of steroids the positive thrombocyte consumption test became negative, but a few days after ending the treatment it became positive again (Vorlander, 1954; Rissel et al., 1957) .
The most pronounced reduction in the thrombocyte count, i.e., the most strongly positive case, was 48-2% of the standard. To study the reproducibility of the thrombocyte consumption test, 25 sera selected at random were analysed successively and the same results were obtained in 76-8 %. Equivalent results seemed to be most frequent in sera which had been repeatedly frozen and thawed.
In some instances, thrombocytes showed fragmentation after the reaction. Since thrombocytes frequently appear as tiny particles under the microscope, the presence of dust or other granules in the preparation may easily give rise to errors; excessively turbid sera should not be used. Parallel analysis was carried out on the sera of adults suffering from various hepatic diseases and those of children suffering from carditis. Homogenized human liver and heart served as antigens. Results are summarized in Table IV .
The serum of one of the eight cardiac children reacted positively both with the heart and the liver antigen: the antihuman globulin consumption test was likewise positive in this case with both antigens.
DISCUSSION
These results justify the conclusion that the thrombocyte consumption test can be used to demonstrate autoantibody-like serum factors which react with homologous tissues. The reaction is based on the phenomenon of 'serological adhesion' (Lamanna, 1957; Nelson and Nelson, 1959) which is a twophased process. First, the antigen-antibody-complement complex is formed, and to this, as a second step, the receptor substance covering the thrombocyte surface is linked. The hypothetical compound in the blood serum promoting the linking was named 'thrombocytobarin' by Kritschewsky and Tscherikower (1925 The method under investigation has the advantage of simplicity. It does not require a serial cold washing of the mixture antigen-test serum, nor does it require an indicator system. This may be why no positive reaction occurred either in the sera of patients suffering from 'other' internal diseases or in those of the healthy individuals. On the other hand, 40% of the patients with infections did give positive reactions which can be explained in two ways. First, in the various infections with a positive thrombocyte consumption test (Table II) the bacterial or virus infection or toxic impact may have injured the liver parenchyma sufficiently to promote the formation of autoantibodies against the hepatic tissue. Secondly, the high positivity might be attributable to the heterogenous character of the antigen: liver homogenate contains not only hepatic cells but connective-tissue elements as well. Possibly the antibodies demonstrated are not liver but connective tissue specific. Further investigations of this hypothesis are in progress.
